Equities

Market movers

Constituents of the FTSE 350 with the highest percent gain over one day.
ListingLastChangeVolume
Greggs PLCGRG:LSE1,596.00
GBX
+82.00
+5.42%
1.48m
Molten Ventures PLCGROW:LSE375.00
GBX
+17.60
+4.92%
626.09k
THG PLCTHG:LSE37.00
GBX
+1.60
+4.52%
5.81m
InterContinental Hotels Group PLCIHG:LSE9,124.00
GBX
+350.00
+3.99%
540.42k
Johnson Service Group PLCJSG:LSE148.40
GBX
+5.00
+3.49%
2.89m
Close Brothers Group PLCCBG:LSE507.00
GBX
+17.00
+3.47%
684.47k
Dr Martens PLCDOCS:LSE94.60
GBX
+3.10
+3.39%
7.75m
Mitchells & Butlers PLCMAB:LSE249.00
GBX
+8.00
+3.32%
396.18k
Hikma Pharmaceuticals PLCHIK:LSE1,644.00
GBX
+52.00
+3.27%
656.85k
Hochschild Mining PLCHOC:LSE351.80
GBX
+11.00
+3.23%
1.58m
Data delayed at least 15 minutes, as of Sep 26 2025 16:25 BST.

Mergers and acquisitions

Mergers and acquisitions across all companies with an updated deal status over the last 90 days

CompaniesDeal statusDeal valueDate
Union Pacific Corp acquired Norfolk Southern CorpAnnounced71.49bn USD29 Jul 2025
Palo Alto Networks Inc acquired Cyberark Software LtdAnnounced25.07bn USD30 Jul 2025
Anglo American PLC acquired Teck Resources LtdAnnounced20.07bn USD08 Sep 2025
Keurig Dr Pepper Inc acquired JDE Peets NVAnnounced18.11bn USD25 Aug 2025
Baker Hughes Co acquired Chart Industries IncAnnounced9.56bn USD29 Jul 2025
84 total results

Institutional Ownership

Company% of available shares heldNet share increase since last reportedValue of change
Mediwound LtdMDWD:NMQ6.52%+37,022.58%11.75m USD
Kaisa Group Holdings Ltd1638:HKG.HZ6.83%+10,652.16%69.82m HKD
Evoke Pharma IncEVOK:NAQ11.02%+2,557.09%891.91k USD
Robex Resources IncRXR:ASX0.00%+2,363.05%2.82m AUD
Burberry Group PLCBURBY:PKL0.10%+2,102.43%5.98m USD
Ontrak IncOTRKQ:PKL0.00%-1.00%-67.00 USD
OrganoClick ABORGC:STO0.00%-1.00%-325.33k SEK
HOOKIPA Pharma IncHOOK:PKL0.00%-1.00%-249.41k USD
Shanghai Aladdin Biochemical Technology Co Ltd688179:SHH0.00%-1.00%-3.09m CNY
JiangXi Tianxin Pharmaceutical Co Ltd603235:SHH0.00%-1.00%-2.79m CNY
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.